PrednisoneVincristineCyclophosphamideGlucocorticoidsDoxorubicinProcarbazineAntineoplastic Combined Chemotherapy ProtocolsMechlorethaminePrednisoloneAzathioprineImmunosuppressive AgentsMelphalanTreatment OutcomeMitoxantroneAntibodies, Monoclonal, Murine-DerivedDrug Therapy, CombinationAnti-Inflammatory AgentsDrug Administration ScheduleBleomycinMethotrexateColor TherapyRemission InductionChlorambucilLymphoma, Non-HodgkinCyclosporineHodgkin DiseaseLymphoma, Large B-Cell, DiffuseMycophenolic AcidVinblastineAsparaginaseAdrenal Cortex HormonesFollow-Up StudiesAdministration, OralThalidomideMultiple MyelomaKidney TransplantationEtoposideSurvival AnalysisGraft RejectionRecurrenceDisease-Free SurvivalTacrolimusMethylprednisoloneSurvival RateTime FactorsCombined Modality TherapyNephrotic SyndromePolymyalgia Rheumatica6-MercaptopurineCyclosporinsEtiocholanoloneLymphoma, FollicularVindesineClinical Trials as TopicCarmustineAndrostenolsTaxoidsPrognosisProspective StudiesCapillary FragilityDouble-Blind MethodImmunosuppressionRetrospective StudiesLomustineEstramustineBoronic AcidsDexamethasonePrecursor Cell Lymphoblastic Leukemia-LymphomaAntineoplastic Agents, HormonalPyrazinesRemission, SpontaneousArthritis, RheumatoidThrombocytopeniaGraft SurvivalDose-Response Relationship, DrugProstatic NeoplasmsFluoxymesterone